Artivion | CRY - Current Liabilities

Stock Price
22.77
Daily Change
-0.16 -0.70%
Monthly
-38.02%
Yearly
-22.84%
Q2 Forecast
24.88

Artivion reported $92.7M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 92.7M 8.86M Mar/2026
AtriCure USD 73.19M 8.33M Mar/2026
Baxter International USD 3.69B 723M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Boston Scientific USD 4.57B 868M Mar/2026
Edwards Lifesciences USD 1.41B 404.7M Mar/2026
Inogen USD 64.94M 2.12M Sep/2025
Integra LifeSciences USD 346.85M 109.14M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 161.03M 9.45M Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
ResMed USD 1.35B 103.1M Mar/2026
Stryker USD 6.32B 1.48B Mar/2026
Surmodics USD 19.44M 1.1M Jun/2025
Tandem Diabetes Care USD 247.96M 5.24M Mar/2026
Teleflex USD 728.05M 33.98M Mar/2026
Terumo JPY 539.7B 243.4B Dec/2025
Trinity Biotech USD 34.49M 2.97M Sep/2025